Mateja
Mateja Burjak, Vrhnika SI
Patent application number | Description | Published |
---|---|---|
20100172969 | HOT-MELT MICROPELLETS - The present invention provides a method of making solid micropellets of which at least 75% by weight have a diameter less than 500 μm comprising (i) melting one or more binders; and (ii) combining the one or more binders melted in step (i) with a pharmaceutically active ingredient to form solid micropellets. Solid micropellets obtainable by this method are also provided. The invention has particular utility for improving the solubility of poorly water-soluble pharmaceutically active ingredients. | 07-08-2010 |
Mateja Burjak, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20100297227 | PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ACTIVE AGENT AND A BINDER, WHICH SWELLS IN AN ACIDIC MEDIA - The invention relates to a pharmaceutical composition, which comprises at least one active agent and which further comprises a binder and/or a retarding agent, wherein the binder swells in an acidic medium, and the retarding agent retards the release of the active agent in an acidic or alkaline medium. | 11-25-2010 |
20120009227 | ACTIVE COATING OF PHARMACEUTICAL DOSAGE FORMS - The present invention describes in an embodiment a coating composition which contains in a film coating an active pharmaceutical ingredient, which is defined by a low water solubility of about 10 mg/ml or lower as measured in water at 20° C. at about pH 7, or which is defined by presenting a dispersed state when placed in water at 20° C. at about pH 7, and a co-polymer of polyvinyl alcohol with polyethylene glycol. Preferably the active pharmaceutical ingredient has been applied dispersed in an aqueous coating vehicle onto a core which optionally comprises a same or different active pharmaceutical ingredient. The present invention also describes a process for the preparation of a pharmaceutical single unit dosage form, wherein the process comprised the steps of providing a core of the single unit dosage form, optionally providing one or more subcoating layer(s) on the core, subjecting the core to film coating using a composition comprising an aqueous coating vehicle, a co-polymer of polyvinyl alcohol with polyethylene glycol and at least one active pharmaceutical ingredient dispersed in the aqueous coating vehicle, wherein said co-polymer amounts for at least 7.0 wt. %, preferably at least 9.4 wt. % of said composition and the weight ratio of said co-polymer to said active pharmaceutical ingredient is at least 1:1 to 5:1. Other process embodiments are also described. High drug loads, uniformity of drug load, and fast dissolution rates of active pharmaceutical ingredient from film coatings of pharmaceutical single unit dosage forms can be achieved according to the present invention. | 01-12-2012 |
20120027854 | PHARMACEUTICAL COMPOSITION COMPRISING EZETIMIBE AND SIMVASTATIN - The present invention belongs to the field of pharmaceutical industry and relates to a process for preparing dosage forms containing simvastatin and ezetimibe, comprising the steps of providing a first composition containing simvastatin, providing a second composition containing ezetimibe, and forming a dosage form comprising at least two separate compartments, wherein one compartment is formed using either the first or the second composition and another compartment is formed using the other composition. The present invention also relates to a process for preparing dosage forms containing simvastatin and ezetimibe, wherein the process involves a direct compression step. Furthermore, the present invention belongs to a dosage form obtained by this process, comprising at least two separate compartments, wherein one compartment contains simvastatin and one compartment contains ezetimibe. Finally, the present invention relates to a combination dosage form comprising a combination of simvastatin and ezetimibe present in two separate compartments of the dosage form. | 02-02-2012 |
Mateja Gabrijel, Novo Mesto SI
Patent application number | Description | Published |
---|---|---|
20140178892 | SCREENING METHODS BASED ON VESICLE MOBILITY - The invention relates to a method of screening for a compound useful in the treatment of a disease selected from neurodegenerative diseases and neuro-inflammatory diseases, said method comprising providing a test cell; staining at least one organelle of said test cell; contacting said test cell with a test compound; and recording the path of said stained organelle in said test cell. Suitable compounds are identified from a comparison of the recorded path with a suitable reference. | 06-26-2014 |
Mateja Mancek Keber, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20080269317 | Compounds for Covalent Binding to MD-2 and Effect on the Immune Response - Compounds having a hydrophobic group with a group and capable of reacting with the cysteine residue for the binding to protein MD-2 are disclosed. The compounds are capable of covalently binding to MD-2, which can be either free or in the complex with other molecules. The compounds are capable of replacing other ligands or preventing a binding of other ligands, especially bacterial endotoxin (lipopolysaccharide-LPS), which can otherwise lead towards unwanted activation of the immune response and acute or chronic inflammatory diseases. | 10-30-2008 |
Mateja Novak Stagoj, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20090047708 | HIGHLY PRODUCTIVE RECOMBINANT YEAST STRAINS WITH MODIFIED GALACTOSE-REGULATED TRANSCRIPTION - A recombinant yeast cell with modified galactose-regulated transcription, a use of such yeast cell, and products made using such yeast cell are disclosed. In such a recombinant yeast cell, a chromosomal gene encoding an enzyme for transformation of a transcription inductor into an inactive product is replaced by a gene encoding a transcription factor for a galactose-inducible promoter. Examples of yeast cells include those from Saccharomycetaceae or Cryptococcaceae families or from the | 02-19-2009 |
Mateja Putic, Charlottesville, VA US
Patent application number | Description | Published |
---|---|---|
20150268152 | SENSING SYSTEMS AND METHODS FOR DETERMINING AND CLASSIFYING CORROSIVITY - A corrosivity associated with each of multiple locations near, on, or within a structure exposed to an environment that can corrode the structure is determined. Each of multiple sensor nodes is mounted at a corresponding one of the locations and measures environmental sensor information using one or more environmental sensors and corrosion sensor information using one or more corrosion sensors. The environmental sensor information is processed to obtain for the sensing node a first atmospheric corrosivity category value in accordance with a corrosivity classification system, and the corrosion sensor information is processed to obtain a second atmospheric corrosivity category value for the sensing node in accordance with the corrosivity classification system. One or more of the first and second atmospheric corrosivity category values is provided for use in determining a corrosion classification value for each of the locations. | 09-24-2015 |
Mateja Salobir, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20090012150 | Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance - The invention relates to the pharmaceutical composition comprising the amorphous active substance which is atorvastatin calcium. The process of stabilization of the pharmaceutical composition comprising the pharmaceutical formulation with amorphous atorvastatin calcium, the process of stabilization of the pharmaceutical formulation comprising amorphous atorvastatin calcium and the process of stabilization of atorvastatin calcium in an amorphous form is described. | 01-08-2009 |